The IBN SINA Pharmaceutical Industry Ltd. announced un-audited earnings results for the third quarter and year to date ended March 31, 2017. For the quarter, EPS was BDT 1.52 as against BDT 1.51 for January-March, 2016. For year to date, EPS was BDT 7.14 as against BDT 6.31 for July, 2015-March, 2016. NOCFPS was BDT 4.75 as against BDT 8.09 for July, 2015-March, 2016. NAV per share was BDT 44.30 as of March 31, 2017 and BDT 33.67 as of June 30, 2016.